Larimar Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Larimar Therapeutics (Nasdaq: LRMR), a clinical-stage biotech company specializing in treatments for complex rare diseases, has announced its participation in two upcoming investor conferences. The company's management team will engage in one-on-one meetings with investors at:

• The Wells Fargo Healthcare Conference in Boston, MA (September 4-6, 2024)
• The H.C. Wainwright 26th Annual Global Investment Conference in New York, NY (September 9-11, 2024)

These conferences provide Larimar with opportunities to connect with potential investors and showcase their progress in developing innovative treatments for rare diseases.

BALA CYNWYD, Pa., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that members of the company’s management team will participate in 1x1 investor meetings at the Wells Fargo Healthcare Conference, taking place September 4-6, 2024 in Boston, MA and the H.C. Wainwright 26th Annual Global Investment Conference, taking place September 9-11, 2024 in New York, NY.

About Larimar Therapeutics
Larimar Therapeutics, Inc. (Nasdaq: LRMR), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. Larimar’s lead compound, nomlabofusp, is being developed as a potential treatment for Friedreich's ataxia. Larimar also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds. For more information, please visit: https://larimartx.com.

Investor Contact:
Joyce Allaire
LifeSci Advisors
jallaire@lifesciadvisors.com
(212) 915-2569

Company Contact:
Michael Celano
Chief Financial Officer
mcelano@larimartx.com
(484) 414-2715

FAQ

What investor conferences will Larimar Therapeutics (LRMR) attend in September 2024?

Larimar Therapeutics will participate in the Wells Fargo Healthcare Conference in Boston from September 4-6, 2024, and the H.C. Wainwright 26th Annual Global Investment Conference in New York from September 9-11, 2024.

What type of meetings will Larimar Therapeutics (LRMR) have at these investor conferences?

Larimar Therapeutics' management team will participate in one-on-one meetings with investors at both conferences.

What is Larimar Therapeutics' (LRMR) focus as a biotechnology company?

Larimar Therapeutics is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases.

Where is Larimar Therapeutics (LRMR) based?

Larimar Therapeutics is based in Bala Cynwyd, Pennsylvania.